Libra Infusions (DHA:LIBRAINFU) Net Margin %: 0.00% (As of . 20)


DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT642.40
View Full Analysis

What is Libra Infusions Net Margin %?

Libra Infusions DHA:LIBRAINFU +0.45% 20 Net Margin % is 0.00% as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100. Among 817 Medical Devices & Instruments companies, Libra Infusions ranks worse than 122398.9% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Libra Infusions's Net Income for the six months ended in . 20 was BDT0.00 Mil. Libra Infusions's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Libra Infusions's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Libra Infusions's Net Margin % or its related term are showing as below:


DHA:LIBRAINFU's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09
* Ranked among companies with meaningful Net Margin % only.

Libra Infusions  (DHA:LIBRAINFU) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Libra Infusions Net Margin % Related Terms

Libra Infusions Net Margin % Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Net Margin % Chart

Libra Infusions Annual Data
Trend
Net Margin %

Libra Infusions Semi-Annual Data
Net Margin %

DHA:LIBRAINFU vs SECI, LENSF, ASNB: Net Margin % Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Libra Infusions Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's Net Margin % distribution charts can be found below:

* The bar in red indicates where Libra Infusions's Net Margin % falls into.


DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Libra Infusions's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Libra Infusions's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Libra Infusions (DHA:LIBRAINFU) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Libra Infusions and its competitors. According to the industry distribution chart, Libra Infusions ranks #999999 out of 817 companies in the Medical Devices & Instruments industry.
Is Libra Infusions' Net Margin % too high?
Libra Infusions' current Net Margin % is 0.00%. Based on the distribution chart, Libra Infusions ranks #999999 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Net Margin % compare to SECI and LENSF?
According to the Medical Devices & Instruments industry distribution chart, Libra Infusions ranks #999999 out of 817 companies for Net Margin %. This places Libra Infusions in the lower half of its industry. The industry median Net Margin % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Libra Infusions and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Libra Infusions's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT642.40
Price